Wyeth Launches Prevnar Vaccine Targeting Pediatric Patients
This article was originally published in PharmAsia News
Executive Summary
Wyeth Japan launched Prevnar pneumococcal vaccine in Japan Feb. 24. The vaccine targets children from 2 months to nine years of age and contains extracts from seven of the most common types of streptococcus pneumoniae bacteria. According to Wyeth, the vaccine can prevent 80 percent of severe infections caused by the bacteria. (Click here for more - Japanese language) "Wyeth Launches Pneumococcal Vaccine Feb. 24, Targets Infants And Children" - Nikkei Sangyo News (2/24/2010)